Cargando…
Correction: Beneficial Role of Rapamycin in Experimental Autoimmune Myositis
Autores principales: | Prevel, Nicolas, Allenbach, Yves, Klatzmann, David, Salomon, Benoit, Benveniste, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892965/ http://dx.doi.org/10.1371/annotation/3eb548ab-c781-4784-9dee-b5a27f7e1643 |
Ejemplares similares
-
Beneficial Role of Rapamycin in Experimental Autoimmune Myositis
por: Prevel, Nicolas, et al.
Publicado: (2013) -
Th1 Response and Systemic Treg Deficiency in Inclusion Body Myositis
por: Allenbach, Yves, et al.
Publicado: (2014) -
The role of interferons type I, II and III in myositis: A review
por: Bolko, Loïs, et al.
Publicado: (2021) -
Correction: Activated dendritic cells modulate proliferation and differentiation of human myoblasts
por: Ladislau, Leandro, et al.
Publicado: (2022) -
Comparison of rapamycin and methylprednisolone for treating inflammatory muscle disease in a murine model of experimental autoimmune myositis
por: Kang, Juan, et al.
Publicado: (2020)